Study Evaluating CERAMENT™|G in Open Diaphyseal Tibial Fractures
Public ClinicalTrials.gov record NCT02820363. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized Multicenter Controlled Trial of CERAMENT™|G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to demonstrate the safety and effectiveness of CERAMENT™\|G used in conjunction with standard-of-care treatment compared to standard-of-care treatment alone in the care of subjects with open fractures of the tibial diaphysis.
Study identification
- NCT ID
- NCT02820363
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 201 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 14, 2017 (Actual)
- Primary completion
- Jul 31, 2021 (Actual)
- Completion
- Jul 31, 2021 (Actual)
- Last update posted
- Aug 10, 2021
2017 – 2021
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294-3409 | — |
| University of California | Irvine | California | 62697 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Cedars Sinai Medical Orthopedic | Los Angeles | California | 90048 | — |
| Harbor-UCLA Medical Center | Los Angeles | California | 90509 | — |
| Denver Health Medical Center | Denver | Colorado | 80204 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| University of Kentucky | Lexington | Kentucky | 40536 | — |
| University of Missouri Health | Columbia | Missouri | 65212 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| University of New Mexico | Albuquerque | New Mexico | 87106 | — |
| New York University, Bellevue Hospital | New York | New York | 10016 | — |
| University of Cincinnati | Cincinnati | Ohio | 45267-0212 | — |
| Department of Orthopedics Greenville Health System | Greenville | South Carolina | 29605 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| University of Texas Health Science Center | San Antonio | Texas | 78229 | — |
| West Virginia University | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02820363, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 10, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02820363 live on ClinicalTrials.gov.